Key advances in the clinical approach to ANCA-associated vasculitis

显微镜下多血管炎 医学 肉芽肿伴多发性血管炎 血管炎 嗜酸性 蛋白酶3 抗中性粒细胞胞浆抗体 疾病 临床试验 病因学 ANCA相关性血管炎 重症监护医学 免疫学 内科学 病理
作者
Cees G. M. Kallenberg
出处
期刊:Nature Reviews Rheumatology [Nature Portfolio]
卷期号:10 (8): 484-493 被引量:145
标识
DOI:10.1038/nrrheum.2014.104
摘要

In this Review of the clinical approach to treating patients with vasculitis, Cees G. M. Kallenberg summarizes the evolution of clinical diagnostic and classification criteria for the vasculitis syndromes. He argues that developments such as testing for ANCA specificity are the basis for a new approach to diagnosis and treatment of patients with AAV. The updated nomenclature for vasculitis defines this varied group of disorders by aetiology, specific features of pathogenesis and clinical symptoms; diagnostic and classification criteria for clinical practice are in development. Here, I review some important advances in the management of vasculitis within the category of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), which encompasses microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA). The clinical approach to the management of the patient with AAV should include testing for ANCA specificity; proteinase 3 (PR3)-specific ANCAs are most often associated with GPA, whereas myeloperoxidase (MPO)-ANCAs are usually associated with MPA. Also important to the management of AAV is an assessment of the disease stage and severity, to enable tailored treatment based on an algorithm derived from controlled-trial data. Remaining questions pertain to the dosage and duration of corticosteroid treatment, the selection of patients for, and duration of, maintenance treatment after induction of remission, and the identification of safer and more effective therapies than are currently in use. Outcome measures should assess not only disease activity, but also damage and quality of life. Infections, cardiovascular events and malignancies also contribute to outcome, and their prevention should therefore be part of the clinical approach to managing patients with AAV.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DW的应助被bqk采纳,获得10
1秒前
汉堡包的应助被着急的青枫采纳,获得10
1秒前
田様的应助被沉默的从安采纳,获得10
2秒前
平常寒烟完成签到,获得积分10
2秒前
高贵的平松完成签到,获得积分10
2秒前
SciGPT的应助被每天都好困采纳,获得10
3秒前
liuqc发布了新的文献求助10
3秒前
XXxx完成签到,获得积分10
3秒前
zhishui发布了新的文献求助10
4秒前
英俊的铭的应助被KimGyuvin采纳,获得10
5秒前
天天快乐的应助被子夜歌采纳,获得10
6秒前
星星完成签到,获得积分10
6秒前
Esther发布了新的文献求助10
6秒前
pillowdamon完成签到,获得积分10
7秒前
zhishui完成签到,获得积分10
9秒前
10秒前
11秒前
12秒前
CONG1完成签到,获得积分10
12秒前
在水一方的应助被pivot_literature采纳,获得10
13秒前
顺顺顺完成签到 ,获得积分10
13秒前
eating完成签到,获得积分10
14秒前
璐璐完成签到,获得积分10
14秒前
hky发布了新的文献求助10
14秒前
pillowdamon发布了新的文献求助10
16秒前
mix完成签到,获得积分10
17秒前
路明非完成签到,获得积分10
19秒前
rslysywd完成签到,获得积分10
19秒前
20秒前
20秒前
可爱的函函的应助被演九胜采纳,获得10
25秒前
25秒前
shi完成签到,获得积分10
25秒前
shaofeng发布了新的文献求助10
26秒前
红烧肉发布了新的文献求助10
26秒前
王亚奇的应助被wyy采纳,获得20
27秒前
旺旺完成签到,获得积分10
27秒前
yyy2025完成签到,获得积分10
27秒前
28秒前
虚拟的画板完成签到 ,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186784
求助须知:如何正确求助?哪些是违规求助? 9575092
关于积分的说明 21839541
捐赠科研通 7784418
什么是DOI,文献DOI怎么找? 3434819
关于科研通互助平台的介绍 2559221
邀请新用户注册赠送积分活动 2481682